Author Affiliations: Section of Infectious Diseases, Department of Medicine, Michael E. DeBakey Veterans Affairs (VA) Medical Center and Baylor College of Medicine, Health Services Research and Development (HSR&D) Center of Excellence, Houston, Texas (Dr Trautner); and Departments of Medicine, VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts, and National Center for Occupational Health and Infection Control, Office of Public Health and Environmental Hazards, Veterans Health Administration, Gainesville, Florida (Dr Gupta).
Approximately 60% of women in the United States experience a UTI, or acute cystitis, during their lifetime. Of these, 30% go on to have multiple recurrences.1 For women who suffer from frequent recurrences, effective preventive strategies are essential to free them from this disruptive illness. Unfortunately, the use of antibiotics for UTI prevention is becoming more problematic because resistance to commonly used agents is now widespread, infection caused by Clostridium difficile is increasingly common, and our appreciation of the importance of an undisturbed microbiome in health is growing. Therefore, investigations of antibiotic-sparing approaches to UTI prevention are of great interest to physicians and patients alike.
Trautner BW, Gupta K. The Advantages of Second Best: Comment on “Lactobacilli vs Antibiotics to Prevent Urinary Tract Infections”. Arch Intern Med. 2012;172(9):712–714. doi:10.1001/archinternmed.2012.1213
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: